DRKS00015034已完成未知
Evaluation of Hemostatics in coagulation inhibited human blood with viscoelastic testing (ROTEM) - HemPIC (Hemostatics in Patients with Inhibited Coagulation)
Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin0 个研究点目标入组 40 人开始时间: 2018年10月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- Male
入选标准
- •Control group:
- •- Healthy, especially concerning coagulation
- •- Informed consent
- •Intervention group:
- •- Regular medication of one of the following medications: Phenprocoumon, Enoxaparin, acetylsalicylic acid and Ticagrelor (combination), Dabigatran, Apixaban
- •- Informed consent
- •- Heparin Group: surgery with a mandatory heparin application during surgery
排除标准
- •Control group:
- •- Bleeding disorders (e.g. haemophilia, factor 5 Leiden mutation)
- •- Medications within the last 10 days
- •- Regular medication
- •- Missing informed consent
- •- Malignancies of the haematopoietic system
- •- Status after diseases which caused a stay at hospital or doctor’s consultation during the last 14 days
- •- HES > 1,5 l during the past 4 weeks
- •Intervention group:
- •- Regular medication of more than one of the following: Phenprocoumon, Enoxaparin, acetylsalicylic acid and Ticagrelor, Dabigatran, Apixaban, acetylsalicylic acid
- •- Medications not at effective level
- •- No intake of the mentioned medications
- •- Intake of medications which influence coagulation but are not analyzed in this study
- •- Bleeding disorders (e.g. haemophilia, factor 5 Leiden mutation)
- •- Malignancies of the haematopoietic system
- •- Surgery in the past 14 days
- •- Stent implantation in the past 3 days
- •- Sepsis in the past 14 days
- •- HES > 1,5 l during the past 4 weeks
- •- Missing informed consent
研究者
相似试验
招募中
不适用
Potential influence of coagulation inhibitionon the perception of fear or aggressivenessI48Atrial fibrillation and flutterDRKS00017043niversitätsklinik für Kardiologie und Angiologie25
尚未招募
3 期
Investigating the effectiveness of anticoagulants compared to aspirin and clopidogrel on disease severity in patients with ischemic stroke.Cerebral infarctionIRCT20221026056307N1Bojnourd University of Medical Sciences86
已完成
不适用
Clinical evaluation on activation of coagulation and fibrinolytic system during major cardiovascular surgerymajor cardiovascular surgery with use of cardiopulmonary bypassJPRN-UMIN000010866Teikyo University Hospital60
尚未招募
不适用
Assessing the correlations of anticoagulant effects between Thromboelastography [TEG] and anti-Xa activity in patients on therapeutic dose of low-molecular-weight heparin (LMWH)?Blood - Other blood disordersAcute coronary syndromeACTRN12609000055202Hayden White60
进行中（未招募）
1 期
Substitution of coagulation factors and blood products in patients with liver cirrhosisiver cirrhosisMedDRA version: 20.0Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871EUCTR2021-006870-22-ATMedical University of Vienna400